Concepedia

Author

Philip J. Bierman

University of Nebraska Medical Center

Also Known As

Bierman, Philip, Braunschweig, Ira, James R. Anderson, P Bierman, P J Bierman, P. Bierman, P. J. Bierman, P.J. Bierman, PHILIP J. BIERMAN, Philip Bierman

304

Publications

10.6K

Citations

61

H-Index

107

Concepts

All Affiliations

University of Nebraska Medical CenterPalmetto Hematology OncologyNebraska Medical CenterThe University of Texas MD Anderson Cancer CenterMemorial Sloan Kettering Cancer Center
PJ

About

Philip J. Bierman is an author at University of Nebraska Medical Center specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

32

65

3.9K

2

Health Sciences

17

22

1K

3

Blood Transplantation

4

4

308

4

Public Health

2

2

29

5

Cardiothoracic Surgery

1

1

10

Philip J. Bierman

×

135

Publications

9.4K

Citations

59

H-Index

YearCitations

Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer

John Nemunaitis, Susan N. Rabinowe, Jack W. Singer,

New England Journal of Medicine

1991

495

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.

Deborah L. Darrington, Julie M. Vose, J R Anderson,

Journal of Clinical Oncology

1994

338

Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma

Kai Fu, Dennis D. Weisenburger, William W.L. Choi,

Journal of Clinical Oncology

2008

336

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

Julie M. Vose, Jamés O. Armitage, Dennis D. Weisenburger,

Journal of Clinical Oncology

1988

272

Central Nervous System Cancers

Burt Nabors, Mario Ammirati, Philip J. Bierman,

Journal of the National Comprehensive Cancer Network

2013

248

NCCN Guidelines Insights: Antiemesis, Version 2.2017

Michael Berger, David S. Ettinger, J N Aston,

Journal of the National Comprehensive Cancer Network

2017

240

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.

Philip J. Bierman, Julie M. Vose, J R Anderson,

Journal of Clinical Oncology

1997

229

Autotransplants for Hodgkin's Disease in Patients Never Achieving Remission: A Report From the Autologous Blood and Marrow Transplant Registry

By Hillard M. Lazarus, Philip A. Rowlings, MEI‐JIE ZHANG,

Journal of Clinical Oncology

1999

189

<scp>MYC</scp> and <scp>BCL</scp>2 protein expression predicts survival in patients with diffuse large <scp>B</scp>‐cell lymphoma treated with rituximab

Anamarija M. Perry, Yuridia Lizeth Alvarado-Bernal, Javier A. Laurini,

British Journal of Haematology

2014

164

Phase I Trial of Iodine-131 Tositumomab With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Relapsed Non-Hodgkin's Lymphoma

Julie M. Vose, Philip J. Bierman, Charles A. Enke,

Journal of Clinical Oncology

2004

161

Page 1